ITMCTR2000003144尚未招募未知
Clinical Research on Treatment of COVID-19 (mild and moderate cases) with Toujiequwen Granules
Guangzhou Eighth People's Hospital0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 80（—）
- 性别
- All
入选标准
- •1. Patients who have been diagnosed as COVID-19 according to The Diagnosis and Treatment Plan for 2019-nCoV(The Fifth Trial Edition);
- •2. aged between 18 to 80 years old, male or female;
- •3. the subjects participating the clinical trial are voluntary and sign the informed consent, thoroughly informed the purpose, method, possible reaction.
排除标准
- •1. Patients who are difficult to be administered orally or by nasal feeding, those who are allergic to the test drug and those who are intolerant to the drug;
- •2. The compliance of medication cannot be guaranteed during the treatment
- •3. Patients with severe primary respiratory diseases, or pneumonia caused by other pathogen.
- •4. Patients with serious diseases, malignant tumors or mental diseases;
- •5. Pregnant women, urine pregnancy test positive;
- •6. Participated in other drug trials in the past month;
- •7. The investigator judged that the patient was not suitable for the study.
研究者
相似试验
尚未招募
不适用
Ozone Therapy for Covid 19 patientsCTRI/2020/07/026671Bisleri charitable trust
尚未招募
不适用
Epidemiology and outcomes of COVID-19 in UdupiCTRI/2020/07/026472Kasturba Medical College Manipal
进行中（未招募）
Unknown
HS COVID-related post-traumatic stress disorder (PTSD) experimental treatment trialPost-Traumatic Stress Disorder (PTSD)Mental and Behavioural DisordersISRCTN52834682King's College London18
进行中（未招募）
1 期
RANDOMISED EVALUATION OF COVID-19 THERAPY (RECOVERY)COVID-19 (infection with SARS-CoV-2 virus)MedDRA version: 21.1Level: PTClassification code 10035737Term: Pneumonia viralSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.1Level: PTClassification code 10061982Term: Severe acute respiratory syndromeSystem Organ Class: 10021881 - Infections and infestationsEUCTR2020-001113-21-GBniversity of Oxford20,000
进行中（未招募）
1 期
Cure COVID: A study to compare the efficacy of GNS561 versus standard treatments in patients with SARS-CoV-2 (COVID-19) infection.COVID-19 infectionMedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestationsEUCTR2020-002249-40-BGGenoscience Pharma120